Peter Cheslock

518 total citations
11 papers, 387 citations indexed

About

Peter Cheslock is a scholar working on Epidemiology, Radiology, Nuclear Medicine and Imaging and Hepatology. According to data from OpenAlex, Peter Cheslock has authored 11 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Hepatology. Recurrent topics in Peter Cheslock's work include Hepatitis B Virus Studies (4 papers), Hepatitis C virus research (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Peter Cheslock is often cited by papers focused on Hepatitis B Virus Studies (4 papers), Hepatitis C virus research (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Peter Cheslock collaborates with scholars based in United States and India. Peter Cheslock's co-authors include Deborah C. Molrine, Rebecca M. Boumil, Brett Leav, Dean Dawson, Gregory J. Babcock, Gavin R. Schnitzler, Aruna Ramachandran, Kirk J. Rowley, Teresa J. Broering and Robert E. Lanford and has published in prestigious journals such as Journal of Biological Chemistry, Nature Genetics and Clinical Infectious Diseases.

In The Last Decade

Peter Cheslock

11 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Cheslock United States	9	138	135	135	106	103	11	387
Aure Saulnier France	8	164 1.2×	169 1.3×	126 0.9×	44 0.4×	82 0.8×	17	380
Xiaohe Lin United States	12	91 0.7×	63 0.5×	156 1.2×	71 0.7×	83 0.8×	15	382
Mariarosaria Naddeo Italy	8	143 1.0×	107 0.8×	157 1.2×	54 0.5×	28 0.3×	12	401
Julián Gómez‐Gutiérrez Spain	13	252 1.8×	195 1.4×	130 1.0×	37 0.3×	47 0.5×	30	379
Virginia Ammendola Italy	8	128 0.9×	49 0.4×	97 0.7×	49 0.5×	16 0.2×	10	355
Anne Fournillier France	16	448 3.2×	531 3.9×	171 1.3×	111 1.0×	218 2.1×	21	740
Charlotte Dalba France	9	209 1.5×	114 0.8×	102 0.8×	49 0.5×	57 0.6×	10	391
Maria L. Knudsen Sweden	7	278 2.0×	293 2.2×	81 0.6×	60 0.6×	95 0.9×	10	443
Freya Van Houtte Belgium	13	229 1.7×	200 1.5×	73 0.5×	23 0.2×	93 0.9×	21	380
Josette Guimet France	5	138 1.0×	116 0.9×	36 0.3×	27 0.3×	30 0.3×	7	361

Countries citing papers authored by Peter Cheslock

Since Specialization

Citations

This map shows the geographic impact of Peter Cheslock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Cheslock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Cheslock more than expected).

Fields of papers citing papers by Peter Cheslock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Cheslock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Cheslock. The network helps show where Peter Cheslock may publish in the future.

Co-authorship network of co-authors of Peter Cheslock

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Cheslock. A scholar is included among the top collaborators of Peter Cheslock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Cheslock. Peter Cheslock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Gogtay, Nithya, Renuka Munshi, D H Ashwath Narayana, et al.. (2017). Comparison of a Novel Human Rabies Monoclonal Antibody to Human Rabies Immunoglobulin for Postexposure Prophylaxis: A Phase 2/3, Randomized, Single-Blind, Noninferiority, Controlled Study. Clinical Infectious Diseases. 66(3). 387–395. 60 indexed citations

Smith, Heidi L., Raymond T. Chung, Parvez Mantry, et al.. (2016). Prevention of allograft HCV recurrence with peri‐transplant human monoclonal antibody MBL‐HCV1 combined with a single oral direct‐acting antiviral: A proof‐of‐concept study. Journal of Viral Hepatitis. 24(3). 197–206. 9 indexed citations

Smith, Heidi L., Peter Cheslock, Mark D. Leney, Bruce Barton, & Deborah C. Molrine. (2016). Potency of a human monoclonal antibody to diphtheria toxin relative to equine diphtheria anti-toxin in a guinea pig intoxication model. Virulence. 7(6). 660–668. 10 indexed citations

Souders, Colby, Sharon E. Maynard, Jing Yan, et al.. (2015). Circulating Levels of sFlt1 Splice Variants as Predictive Markers for the Development of Preeclampsia. International Journal of Molecular Sciences. 16(6). 12436–12453. 21 indexed citations

Sevigny, Leila M., Kirk J. Rowley, Brett Leav, et al.. (2013). Identification of a Human Monoclonal Antibody To Replace Equine Diphtheria Antitoxin for Treatment of Diphtheria Intoxication. Infection and Immunity. 81(11). 3992–4000. 21 indexed citations

Morin, Trevor J., Teresa J. Broering, Brett Leav, et al.. (2012). Human Monoclonal Antibody HCV1 Effectively Prevents and Treats HCV Infection in Chimpanzees. PLoS Pathogens. 8(8). e1002895–e1002895. 133 indexed citations

Gogtay, Nithya, Urmila Thatte, Nilima Kshirsagar, et al.. (2012). Safety and pharmacokinetics of a human monoclonal antibody to rabies virus: A randomized, dose-escalation phase 1 study in adults. Vaccine. 30(50). 7315–7320. 33 indexed citations

Leav, Brett, et al.. (2010). 281 SAFETY AND PHARMACOKINETICS OF A NOVEL HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST THE E2 GLYCOPROTEIN OF HEPATITIS C VIRUS (MBL-HCV1) IN HEALTHY VOLUNTEERS. Journal of Hepatology. 52. S118–S118. 2 indexed citations

Broering, Teresa J., Gregory J. Babcock, R Finberg, et al.. (2009). 1048 A NOVEL HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST THE E2 GLYCOPROTEIN OF HEPATITIS C VIRUS (HCV) PREVENTS INFECTION IN CHIMPANZEES. Journal of Hepatology. 50. S381–S381. 3 indexed citations

10.

Cheslock, Peter, et al.. (2005). The roles of MAD1, MAD2 and MAD3 in meiotic progression and the segregation of nonexchange chromosomes. Nature Genetics. 37(7). 756–760. 54 indexed citations

11.

Ramachandran, Aruna, et al.. (2003). Linker Histone H1 Modulates Nucleosome Remodeling by Human SWI/SNF. Journal of Biological Chemistry. 278(49). 48590–48601. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact